Wave Life Sciences Ltd.
NASDAQ:WVE
12.24 (USD) • At close February 5, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities: | |||||||||||
| Net Income
| -57.513 | -161.823 | -122.245 | -149.91 | -193.638 | -146.653 | -102.035 | -55.401 | -19.2 | -5.229 | -3.318 |
| Depreciation & Amortization
| 9.206 | 10.114 | 9.835 | 9.983 | 9.201 | 5.581 | 2.155 | 0.784 | 0.594 | 0.281 | 0.276 |
| Deferred Income Tax
| 0 | 0 | -12.644 | -9.145 | -31.408 | 0.044 | 0.774 | -0.874 | 0.036 | 0.084 | -0.33 |
| Stock Based Compensation
| 9.795 | 17.194 | 16.407 | 14.296 | 19.509 | 15.596 | 12.143 | 6.847 | 4.024 | 0 | 0 |
| Change In Working Capital
| 19.081 | 6.722 | 7.01 | 9.649 | -23.303 | 102.387 | -0.299 | 16.207 | 1.931 | 0.43 | -0.173 |
| Accounts Receivables
| -21.086 | 0 | 30 | 20 | 10 | -59 | -1 | 0 | 0.193 | -0.129 | -0.102 |
| Inventory
| 0 | 0 | 2.041 | 4.609 | -5.454 | -4.082 | 0 | 0 | 0.242 | 0.398 | 0 |
| Accounts Payables
| -3.761 | 9.348 | -6.567 | 5.117 | -3.497 | 4.936 | 3.892 | 3.369 | 1.648 | 0.009 | -0.152 |
| Other Working Capital
| 43.928 | -2.626 | -18.464 | -20.077 | -24.352 | 160.533 | -4.191 | 12.838 | -0.152 | 0.152 | 0.081 |
| Other Non Cash Items
| 0 | 0.012 | 12.644 | 9.145 | 31.408 | 0.183 | 3.591 | 0.565 | 0.088 | -0.006 | -0.006 |
| Operating Cash Flow
| -19.431 | -127.781 | -88.993 | -115.982 | -188.231 | -22.862 | -83.671 | -31.872 | -12.527 | -4.426 | -3.551 |
| Investing Activities: | |||||||||||
| Investments In Property Plant And Equipment
| -1.115 | -1.361 | -0.56 | -1.338 | -3.918 | -9.938 | -18.887 | -5.567 | -1.857 | -0.59 | -0.047 |
| Acquisitions Net
| 0 | 0.106 | 0 | 0 | 0 | 0 | 0 | 0.004 | 0.003 | 0 | 0 |
| Purchases Of Investments
| 0 | -75.044 | 0 | 0 | 0 | 0 | 0 | -2.599 | -1.055 | 0 | 0 |
| Sales Maturities Of Investments
| 0 | 75.044 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Investing Activites
| 0 | 0.106 | 0 | 0 | -3.918 | -9.938 | -0.009 | -2.595 | -1.052 | 0.333 | 0 |
| Investing Cash Flow
| -1.115 | -1.255 | -0.56 | -1.338 | -3.918 | -9.938 | -18.896 | -8.162 | -2.909 | -0.257 | -0.047 |
| Financing Activities: | |||||||||||
| Debt Repayment
| 0 | 0 | 0 | 0 | 0 | -0.016 | -0.062 | -0.062 | -0.126 | 0 | 0 |
| Common Stock Issued
| 131.277 | 52.325 | 54.97 | 153.626 | 161.792 | 60 | 93.509 | 30 | 113.075 | 5.585 | 0 |
| Common Stock Repurchased
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities
| 1.257 | 14.863 | 0.858 | 0.912 | 2.607 | 5.11 | 0.927 | -0.817 | 62.644 | 0.034 | 3.672 |
| Financing Cash Flow
| 132.534 | 67.188 | 55.828 | 154.538 | 164.399 | 65.094 | 94.374 | 29.121 | 175.593 | 5.619 | 3.672 |
| Other Information: | |||||||||||
| Effect Of Forex Changes On Cash
| -0.095 | -0.21 | -0.208 | 0.122 | 0.114 | 0.037 | 0.403 | -0.014 | 0.015 | -0.327 | -0.014 |
| Net Change In Cash
| 111.893 | -62.058 | -33.933 | 37.34 | -27.636 | 32.331 | -7.79 | -10.927 | 160.172 | 0.609 | 0.06 |
| Cash At End Of Period
| 204.05 | 92.157 | 154.215 | 188.148 | 150.808 | 178.444 | 142.503 | 150.293 | 161.22 | 1.048 | 0.439 |